CHD7 (UniProtKB/Swiss-Prot entry Q9P2D1) is a putative transcription regulator which may be involved in 45S precursor rRNA
production. Mutations in CHD7 have been found in some patients with the CHARGE syndrome.
|Species reactivity||Human: positive. Other species: not tested.|
|Purity||Affinity purified polyclonal antibody in TBS containing 0.1% BSA and 0.09% azide.|
|Storage Conditions||Store at 4°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|ChIP/ChIP-seq *||4 μg/ChIP||Fig 1, 2|
|Western Blotting||1:1,000||Fig 3|
* Please note that the optimal antibody amount per IP should be determined by the end-user. We recommend testing 1-5 μg per IP.
1Manufactured by Bethyl Laboratories, Inc., Texas, USA